sickle cell disease - Articles and news items

Novartis’ Phase II antibody trial reduces frequency of sickle cell pain crises

Industry news / 6 December 2016 / Niamh Louise Marriott, Digital Editor

Results from the Phase II study show that SEG101 an anti-P-selectin antibody, reduced the median annual rate of sickle cell-related pain crises by 45.3%…

BMS in sickle cell partnership to help treat Angolan children

Industry news / 27 June 2016 / Victoria White, Digital Content Producer

The Angola Sickle Cell Initiative and Bristol-Myers Squibb are teaming up to provide children with sickle cell disease in Angola with Droxia…

Managed Access Program for sickle cell disease treatment, PGLG

Industry news / 26 May 2016 / Victoria White, Digital Content Producer

A Managed Access Program (MAP) for the treatment of sickle cell disease has been announced for Emmaus’ pharmaceutical grade L-glutamine treatment (PGLG)…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+